1.Which of the following is not a key component of overactive bladder symptoms?

Urgency

Nocturia

Inability to completely empty bladder

Frequency

2.Risk factors for OAB include all of the following except:

Obesity

Older age

Diabetes mellitus

Hyperlipidemia 

3.Which of the following should be included in the initial OAB work-up?

Urodynamics

Urinalysis

Cystoscopy

Bladder ultrasound

4.Antimuscarinics should be used with caution in elderly patients with OAB due to an increased risk of:

Seizures

Gastrointestinal bleeding

Cognitive impairment

Bone density loss

5.In the BESIDE study of adult OAB patients, mirabegron (50 mg) add-on therapy to low-dose solifenacin (5 mg) resulted in:

Similar effectiveness as low-dose solifenacin (5 mg)

Lower rates of treatment-emergent adverse events as compared to high-dose solifenacin (10 mg) monotherapy

Minimal effectiveness among older patients

Lower effectiveness as compared to high-dose solifenacin (10 mg)

6.Referral to a urologist should be considered in the presence of any of the following findings except:

2 or more incontinent episodes per day

Hematuria

Pelvic pain

Neurogenic bladder

7.According to the AUA/SUFU guidelines on OAB, for a patient with an inadequate response to behavioral therapy, second-line treatment can include all of the following except:

Oral antimuscarinic

Beta-3 agonist

Botulinum toxin injection

Combination therapy with an antimuscarinic and beta-3 agonist